EligibleTrials

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Recruiting · NCT06911632 · Interventional (participants receive a specific treatment) · Lead sponsor: Tempus AI

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

ECG-based AI Device - Results Not Returned to InvestigatorECG-based AI Device - Results Returned to InvestigatorEchocardiogram and Right Heart Catheterization

What this trial is about

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

37 locations listed across 28 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.